Trial
NCT03866538
Budesonide in Patients With Immune Mediated Enteropathies
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Enteropathy
Intervention
Withdrawal of Oral Budesonide
Why stopped
Study recruitment was difficult and not acheived
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-26